Global Type-2 Diabetes Market Analysis, 2020

Global Type-2 Diabetes Market Analysis, 2020

By Drug Type (Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Alpha-glucosidase Inhibitors, Biguanides, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2), Read more

  • Healthcare
  • Jun 2020
  • 178
  • HC22021

The Global Type-2 Diabetes Market Analysis, 2020 market research report depicts a deep-dive market analysis of statistics of the Global Type-2 Diabetes market, which consists of regional and country-wise analysis of the market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market shares of various end users, applications, product type, technologies, competitive benchmarking, etc.

According to MarkNtel Advisors’ research report titled “Global Type-2 Diabetes Market Analysis, 2020”, the market is anticipated to grow at a CAGR of around 8% during 2020-25 on account of the increasing prevalence of type 2 diabetes due to issues related to being overweight, physical inactiveness, and obesity. In addition, the rising geriatric population along with the surging population with type-1 diabetes and lack of proper healthcare infrastructure in the emerging countries is projected to boost the growth of the type-2 Diabetes market globally in the forthcoming years.

High Type-2 Diabetes Occurrence in Women

Based on gender, women hold a significant market share in the Global Type-2 Diabetes market 2019 owing to the rising prevalence of type-2 diabetes among pregnant women. Due to multiple adverse pregnancy outcomes, the development of gestational diabetes is high among pregnant women. In addition, the chance of developing type 2 diabetes is high, especially in three to six years after delivery. However, exposure to hyperglycemia in the womb affects the health of children resulting in overweight which make them more prone to developing type 2 diabetes in the coming years. Thus, it is projected to accentuate the market growth of type-2 diabetes in the forecasted period.

North America Segment Registered the Fastest Growth

North America captured a considerable market share in the Global Type-2 Diabetes market in 2019. The US acquired the majority market share in the region owing to the boost in the rate of obesity, cardiovascular, and chronic diseases in the country which has proliferated the growth of type-2 diabetes in people.

However, an astronomical growth in the number of type-2 diabetes is foreseen in the Asia-Pacific region. During the 21st century, it is projected that a large number of new diabetes cases would occur each year in the region due to the rising rate of obesity, increasing geriatric population, and poor-quality lifestyle of the people. The number of people with diabetes in Southeast Asia is 80 million in 2017 and is anticipated to surge to 151 million by the year 2045. Thus, these factors are projected to strongly contribute toward the growth of the Type-2 Diabetes market in the coming years as stated in the MarkNtel Advisors’ research report “Global Type-2 Diabetes Market Analysis, 2020”. 

According to MarkNtel Advisors, the key players with a considerable market share in the Global Type-2 Diabetes market include Merck & Co, AstraZeneca, Novo Nordisk. Bristol-Myers Squibb, Eli Lilly, Sanofi, Boehringer Ingelheim, Pfizer, Takeda, Biocon, Johnson & Johnson etc. To gain a competitive edge over the other market players, these companies are collaborating with other pharmaceutical firms for the launch of the products in other markets as well with an aim to have a strong foothold globally. Moreover, to make the diabetes digital health space less congested, the companies have entered the digital market by launching mobile health apps for the customer to ease them by keeping the track of their type 2 diabetes regimes.

Key Questions Answered in the Market Research Report 

  1. What are the key overall market statistics or market estimates (Market Overview, Market Size- By Value, Forecast Numbers, Market Segmentation, Market Shares) of Global Type-2 Diabetes Market?
  2. What is the region-wise industry size, growth drivers and challenges key market trends?
  3. What are the key innovations, technology upgrades, opportunities, regulations in the Global Type-2 Diabetes Market?  
  4. Who are the key competitors or market players and how they perform in Global Type-2 Diabetes Market based on the competitive benchmarking matrix?
  5. What are the key results derived from the market surveys conducted during the course of Global Type-2 Diabetes Market study?   

 Market Outlook, Segmentation and Statistics 

  • Impact of COVID-19
    • Short Term Impact
    • Long Term Impact
    • Market Size & Analysis
      • By Revenues (USD Million)
    • Market Share & Analysis
      • By Drug Type
        • Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
        • Alpha-glucosidase Inhibitors
        • Biguanides
        • Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
        • Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2)
        • Sulfonylureas
        • Other (Thiazolidinediones, meglitinides, glitazones, etc.)
      • By Gender
        • Male
        • Female
      • By Age Group
        • Upto 19 years
        • 20 – 65 years
        • Above 65 years
      • By Region
  • North America Type-2 Diabetes Market Outlook, 2015-2025F (USD Million)
    • The US Type-2 Diabetes Market Outlook, 2015-2025F (USD Million)
    • Canada Type-2 Diabetes Market Outlook, 2015-2025F (USD Million)
    • Mexico Type-2 Diabetes Market Outlook, 2015-2025F (USD Million)
  • South America Type-2 Diabetes Market Outlook, 2015-2025F (USD Million)
    • Brazil Type-2 Diabetes Market Outlook, 2015-2025F (USD Million)
    • Argentina Type-2 Diabetes Market Outlook, 2015-2025F (USD Million)
  • Europe Type-2 Diabetes Market Outlook, 2015-2025F (USD Million)
    • The UK Type-2 Diabetes Market Outlook, 2015-2025F (USD Million)
    • Germany Type-2 Diabetes Market Outlook, 2015-2025F (USD Million)
    • France Type-2 Diabetes Market Outlook, 2015-2025F (USD Million)
    • Italy Type-2 Diabetes Market Outlook, 2015-2025F (USD Million)
    • Spain Type-2 Diabetes Market Outlook, 2015-2025F (USD Million
  • Middle East & Africa Type-2 Diabetes Market Outlook, 2015-2025F (USD Million)
    • UAE Type-2 Diabetes Market Outlook, 2015-2025F (USD Million)
    • Saudi Arabia Type-2 Diabetes Market Outlook, 2015-2025F (USD Million)
    • South Africa Type-2 Diabetes Market Outlook, 2015-2025F (USD Million)
  • Asia-Pacific Type-2 Diabetes Market Outlook, 2015-2025F (USD Million)
    • China Type-2 Diabetes Market Outlook, 2015-2025F (USD Million)
    • Japan Type-2 Diabetes Market Outlook, 2015-2025F (USD Million)
    • India Type-2 Diabetes Market Outlook, 2015-2025F (USD Million)
    • South-East Asia Type-2 Diabetes Market Outlook, 2015-2025F (USD Million)
    • Australia Type-2 Diabetes Market Outlook, 2015-2025F (USD Million)
    • South Korea Type-2 Diabetes Market Outlook, 2015-2025F (USD Million)
      • By Company
        • Revenue Shares
        • Strategic Factorial Indexing
        • Competitor Placement in MarkNtel Quadrant
  • Global Type-2 Diabetes Market Policies, Regulations, Product Standard
  • Global Type-2 Diabetes Market Hotspots & Opportunities
  • Competition Outlook
    • Competitor Wise Growth Strategies
    • Company Profiles

Frequently Asked Questions 

Q. What is the historical year, base year and forecast year considered in the research report on Global Type-2 Diabetes Market?

A. The historical data has been provided since 2015, while the base year is 2019 and the data is forecast up-to 2025.

Q. What are the units or denomination for measuring market value and volume in the report?
A. The market size/industry size or the market value is measured in terms of USD Million.

Q. What would be the growth rate or CAGR of Global Type-2 Diabetes Market during 2020-25?
A. The growth rate of Global Type-2 Diabetes Market during 2020-25 is forecast to be around 8%.

Q. Who are the key competitors or players operating in Global Type-2 Diabetes Market? 
A. Merck & Co, AstraZeneca, Novo Nordisk. Bristol-Myers Squibb, Eli Lilly, Sanofi, Boehringer Ingelheim, Pfizer, Takeda, Biocon, Johnson & Johnson etc., are few of the leading players in the Global Type-2 Diabetes Market.

Q. Which gender segment would emerge as an opportunity area for players in Global Type-2 Diabetes Market?

A. Women segment is expected to attain the highest CAGR during the forecast period and maintain its significant market share.

Q. Which region would emerge as an opportunity area for players in Global Type-2 Diabetes Market?
A. The North America grabbed a significant market share continue to grow at a highest CAGR, presenting immense opportunities for manufacturers and suppliers of Global Type-2 Diabetes Market.

  1. Introduction
    1. Research Process
    2. Market Segmentation
    3. Market Definition
    4. Assumptions
  2. Executive Summary
  3. Expert Verbatim
  4. Impact of Covid-19
    1. Short Term Impact
    2. Long Term Impact
  5. Global Type 2 Diabetes Market Outlook, 2015-25F
    1. Market Size & Analysis
      1. Market Revenues
    2. Market Share & Analysis
      1. By Drug Type
        1. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
        2. Alpha-glucosidase Inhibitors
        3. Biguanides
        4. Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
        5. Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2)
        6. Sulfonylureas
        7. Other (Thiazolidinediones, Meglitinides, Glitazones, etc.)
      2. By Gender
        1. Male
        2. Female
      3. By Age Group
        1. Upto 19 years
        2. 20 – 65 years
        3. Above 65 years
      4. By Region
        1. North America
        2. South America
        3. Europe
        4. Middle East & Africa
        5. Asia-Pacific
      5. By Company
        1. Revenue Shares
        2. Strategic Factorial Indexing
        3. Competitor Placement in MarkNtel Quadrant
    3. Market Attractiveness Index
      1. By Drug Type
      2. By Gender
      3. By Age Group
      4. By Region
  6. North America Type 2 Diabetes Market Outlook, 2015-25F
    1. Market Size & Analysis
      1. Market Revenues
    2. Market Share & Analysis
      1. By Drug Type
      2. By Gender
      3. By Age Group
      4. By Country
        1. The US
        2. Canada
        3. Mexico
    3. Market Attractiveness Index
      1. By Drug Type
      2. By Gender
      3. By Age Group
      4. By Country
    4. The US Type 2 Diabetes Market Outlook, 2015-25F
      1. Market Size & Analysis
        1. Market Revenues
      2. Market Share & Analysis
        1. By Drug Type
    5. Canada Type 2 Diabetes Market Outlook, 2015-25F
      1. Market Size & Analysis
        1. Market Revenues
      2. Market Share & Analysis
        1. By Drug Type
    6. Mexico Type 2 Diabetes Market Outlook, 2015-25F
      1. Market Size & Analysis
        1. Market Revenues
      2. Market Share & Analysis
        1. By Drug Type
    7. Competitive Scenario for various Countries
      1. Mapping Countries and Market Potential (High, Medium, Low)
      2. Companies Dominating in Countries
  7. South America Type 2 Diabetes Market Outlook, 2015-25F
    1. Market Size & Analysis
      1. Market Revenues
    2. Market Share & Analysis
      1. By Drug Type
      2. By Gender
      3. By Age Group
      4. By Country
        1. Brazil
        2. Argentina
        3. Others
    3. Market Attractiveness Index
      1. By Drug Type
      2. By Gender
      3. By Age Group
      4. By Country
    4. Brazil Type 2 Diabetes Market Outlook, 2015-25F
      1. Market Size & Analysis
        1. Market Revenues
      2. Market Share & Analysis
        1. By Drug Type
    5. Argentina Type 2 Diabetes Market Outlook, 2015-25F
      1. Market Size & Analysis
        1. Market Revenues
      2. Market Share & Analysis
        1. By Drug Type
    6. Competitive Scenario for various Countries
      1. Mapping Countries and Market Potential (High, Medium, Low)
      2. Companies Dominating in Countries
  8. Europe Type 2 Diabetes Market Outlook, 2015-25F
    1. Market Size & Analysis
      1. Market Revenues
    2. Market Share & Analysis
      1. By Drug Type
      2. By Gender
      3. By Age Group
      4. By Country
        1. The UK
        2. Germany
        3. France
        4. Italy
        5. Spain
        6. Others
    3. Market Attractiveness Index
      1. By Drug Type
      2. By Gender
      3. By Age Group
      4. By Country
    4. The UK Type 2 Diabetes Market Outlook, 2015-25F
      1. Market Size & Analysis
        1. Market Revenues
      2. Market Share & Analysis
        1. By Drug Type
    5. Germany Type 2 Diabetes Market Outlook, 2015-25F
      1. Market Size & Analysis
        1. Market Revenues
      2. Market Share & Analysis
        1. By Drug Type
    6. France Type 2 Diabetes Market Outlook, 2015-25F
      1. Market Size & Analysis
        1. Market Revenues
      2. Market Share & Analysis
        1. By Drug Type
    7. Italy Type 2 Diabetes Market Outlook, 2015-25F
      1. Market Size & Analysis
        1. Market Revenues
      2. Market Share & Analysis
        1. By Drug Type
    8. Spain Type 2 Diabetes Market Outlook, 2015-25F
      1. Market Size & Analysis
        1. Market Revenues
      2. Market Share & Analysis
        1. By Drug Type
    9. Competitive Scenario for various Countries
      1. Mapping Countries and Market Potential (High, Medium, Low)
      2. Companies Dominating in Countries
  9. Middle East & Africa Type 2 Diabetes Market Outlook, 2015-25F
    1. Market Size & Analysis
      1. Market Revenues
    2. Market Share & Analysis
      1. By Drug Type
      2. By Gender
      3. By Age Group
      4. By Country
        1. UAE
        2. Saudi Arabia
        3. South Africa
        4. Others
    3. Market Attractiveness Index
      1. By Drug Type
      2. By Gender
      3. By Age Group
      4. By Country
    4. UAE Type 2 Diabetes Market Outlook, 2015-25F
      1. Market Size & Analysis
        1. Market Revenues
      2. Market Share & Analysis
        1. By Drug Type
    5. Saudi Arabia Type 2 Diabetes Market Outlook, 2015-25F
      1. Market Size & Analysis
        1. Market Revenues
      2. Market Share & Analysis
        1. By Drug Type
    6. South Africa Type 2 Diabetes Market Outlook, 2015-25F
      1. Market Size & Analysis
        1. Market Revenues
      2. Market Share & Analysis
        1. By Drug Type
    7. Competitive Scenario for various Countries
      1. Mapping Countries and Market Potential (High, Medium, Low)
      2. Companies Dominating in Countries
  10. Asia-Pacific Type 2 Diabetes Market Outlook, 2015-25F
    1. Market Size & Analysis
      1. Market Revenues
    2. Market Share & Analysis
      1. By Drug Type
      2. By Gender
      3. By Age Group
      4. By Country
        1. China
        2. India
        3. Japan
        4. South Korea
        5. Australia
        6. South East Asia
        7. Others
    3. Market Attractiveness Index
      1. By Drug Type
      2. By Gender
      3. By Age Group
      4. By Country
    4. China Type 2 Diabetes Market Outlook, 2015-25F
      1. Market Size & Analysis
        1. Market Revenues
      2. Market Share & Analysis
        1. By Drug Type
    5. India Type 2 Diabetes Market Outlook, 2015-25F
      1. Market Size & Analysis
        1. Market Revenues
      2. Market Share & Analysis
        1. By Drug Type
    6. Japan Type 2 Diabetes Market Outlook, 2015-25F
      1. Market Size & Analysis
        1. Market Revenues
      2. Market Share & Analysis
        1. By Drug Type
    7. South Korea Type 2 Diabetes Market Outlook, 2015-25F
      1. Market Size & Analysis
        1. Market Revenues
      2. Market Share & Analysis
        1. By Drug Type
    8. Australia Type 2 Diabetes Market Outlook, 2015-25F
      1. Market Size & Analysis
        1. Market Revenues
      2. Market Share & Analysis
        1. By Drug Type
    9. South East Asia Type 2 Diabetes Market Outlook, 2015-25F
      1. Market Size & Analysis
        1. Market Revenues
      2. Market Share & Analysis
        1. By Drug Type
    10. Competitive Scenario for various Countries
      1. Mapping Countries and Market Potential (High, Medium, Low)
      2. Companies Dominating in Countries
  11. Global Type 2 Diabetes Regulations, Product Standards
  12. Global Type 2 Diabetes Value Chain Analysis
  13. Consumer Behavior Analysis
    1. Consumer Trends and Preferences
    2. Factors Affecting Buying Decision
  14. Global Type 2 Diabetes Market Dynamics
    1. Drivers
    2. Challenges
    3. Impact Analysis
  15. Global Type 2 Diabetes Market Hotspots & Opportunities
  16. Global Type 2 Diabetes Market Trends & Insights
  17. Global Type 2 Diabetes Price Analysis
  18. Global Type 2 Diabetes Market Key Strategic Imperatives for Success & Growth
  19. Competition Outlook
    1. Competitor Wise Growth Strategies
      1. Product Portfolio
      2. Target Market
      3. Target Age Group
      4. Manufacturing Units
      5. Research & Development
      6. Strategic Alliances & Initiatives
    2. Company Profiles of top companies (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
      1. Merck & Co
      2. AstraZeneca
      3. Novo Nordisk
      4. Bristol-Myers Squibb
      5. Eli Lilly
      6. Sanofi
      7. Boehringer Ingelheim
      8. Pfizer
      9. Takeda
      10. Biocon
      11. Johnson & Johnson
  20. Disclaimer
Global Type-2 Diabetes Market Segmentation